Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Metastasectomy and Chemotherapy for Lung Metastases from Soft Tissue Sarcoma
NCT00002764Phase 3Completed
- Sponsor
- European Organisation for Research and Treatment of Cancer
- Start
- Apr 1996
- Primary completion
- Nov 2000
- Modality
- DNA Intercalators/Alkylators
- Countries
- 1
01
Overview
A Phase 3 trial of doxorubicin, ifosfamide in soft tissue sarcoma (STS), sponsored by European Organisation for Research and Treatment of Cancer. Started Apr 1996; status: completed.
02
Drugs
doxorubicinifosfamide
03
Conditions
soft tissue sarcoma (STS)
Beyond the preview
Go deeper on NCT00002764.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00002764.